Literature DB >> 1931728

Obesity and hepatotoxins as risk factors for fatty liver disease.

M Hodgson1, D H van Thiel, B Goodman-Klein.   

Abstract

Generally fatty liver disease (FLD) is attributed either to alcohol, diabetes mellitus, or obesity. To evaluate this commonly held clinical belief, a case-control study of FLD in Western Pennsylvania was conducted with 19 cases being identified over a two year period. Cases of FLD were significantly heavier and were significantly more likely than controls to have exposures to either agents with recognised animal hepatotoxicity (odds ratio [OR] 8, p = 0.018) or to agents with potential hepatotoxicity--that is, documented in humans, animals, or expected on the basis of structure activity relations (OR = 4.5; p = 0.18). By contrast, they had not consumed significantly more alcohol than the controls. A logistic regression model of this experience suggests that both exposure to hepatotoxins and obesity are independent risk factors for FLD, which have an additive rather than a multiplicative interaction. Based upon these data, an occupational exposure to either recognised or potential hepatotoxins should be considered as a cause of liver dysfunction in subjects with FLD, independent of obesity and a history of alcohol consumption.

Entities:  

Mesh:

Year:  1991        PMID: 1931728      PMCID: PMC1012062          DOI: 10.1136/oem.48.10.690

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  13 in total

1.  Evaluation of blood donors with elevated serum alanine aminotransferase levels.

Authors:  L S Friedman; J L Dienstag; E Watkins; C A Hinkle; J A Spiers; S V Rieder; C E Huggins
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

2.  Inter-rater agreement in assessing occupational exposure in a case-control study.

Authors:  M S Goldberg; J Siemiatycki; M Gérin
Journal:  Br J Ind Med       Date:  1986-10

3.  Changes in serum enzymes in moderate drinkers after an alcohol challenge.

Authors:  E Nemesánszky; J A Lott; M Arato
Journal:  Clin Chem       Date:  1988-03       Impact factor: 8.327

4.  Modeling and variable selection in epidemiologic analysis.

Authors:  S Greenland
Journal:  Am J Public Health       Date:  1989-03       Impact factor: 9.308

5.  Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis.

Authors:  W J Shergy; R P Polisson; D S Caldwell; J R Rice; D S Pisetsky; N B Allen
Journal:  Am J Med       Date:  1988-12       Impact factor: 4.965

6.  Obtaining occupational exposure histories in epidemiologic case-control studies.

Authors:  M Gérin; J Siemiatycki; H Kemper; D Bégin
Journal:  J Occup Med       Date:  1985-06

7.  Interaction between drugs and solvents as a cause of fatty change in the liver?

Authors:  C Edling
Journal:  Br J Ind Med       Date:  1982-05

8.  Chemical hepatitis: pathogenesis, detection and management.

Authors:  C H Tamburro
Journal:  Med Clin North Am       Date:  1979-05       Impact factor: 5.456

9.  Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury.

Authors:  A M Diehl; Z Goodman; K G Ishak
Journal:  Gastroenterology       Date:  1988-10       Impact factor: 22.682

10.  Clinical and pathological characteristics of hepatotoxicity associated with occupational exposure to dimethylformamide.

Authors:  C A Redlich; A B West; L Fleming; L D True; M R Cullen; C A Riely
Journal:  Gastroenterology       Date:  1990-09       Impact factor: 22.682

View more
  2 in total

1.  Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey.

Authors:  K Tominaga; J H Kurata; Y K Chen; E Fujimoto; S Miyagawa; I Abe; Y Kusano
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

2.  Sonographic assessment of petroleum-induced hepatotoxicity in Nigerians: does biochemical assessment underestimate liver damage?

Authors:  Angel-Mary Anakwue; Raphael Anakwue; Mark Okeji; Felicitas Idigo; Kenneth Agwu; Uloma Nwogu
Journal:  Afr Health Sci       Date:  2017-03       Impact factor: 0.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.